Navigation Links
Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
Date:12/11/2007

ROCHESTER, N.Y., Dec. 11 /PRNewswire/ -- Lucid, Inc. (http://www.lucid-tech.com), a leading U.S. cellular imaging and technology company, has appointed Dr. Colin Stahel as Director, Asia Pacific Region.

Based in Sydney, Australia, Stahel was selected for the newly created position based on his extensive medical technology experience.

"With over twenty years of experience in the development of medical technology and pre-cancer and cancer detection equipment, Stahel is a welcome addition to the Lucid team," said Jay Eastman, chairman and CEO of Lucid, Inc (http://www.lucid-tech.com). "His knowledge of the field will suit his new responsibilities in the international community."

Previously, Stahel was the senior manager with Polartechnics where he worked directly with the SolarScan digital dermatoscope and TruScreen Division for real time detection of cervical cancer, both based in Australia.

Dr. Colin D. Stahel holds a Ph.D. in physiology from the Faculty of Medicine, University of Tasmania in Australia, and a MBA from Macquarie University of Australia.

Lucid is the creator of the non-invasive VivaScope confocal microscope that provided cellular resolution images of skin, and of the VivaNet, an internet-based, DICOM-compliant medical information systems that enables the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. Lucid's VivaScopes are in regular use throughout the United States, Europe, and Australia.

For more information about Lucid Inc., visit http://www.Lucid-tech.com or call 1-585-239-9800.

About Lucid, Inc.

Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope(R) cellular resolution images to medical professionals. The Company's digital VivaNet(TM) server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.Lucid-tech.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jay Eastman, Ph.D. http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62055


'/>"/>
SOURCE Lucid, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/7/2020)... ... 06, 2020 , ... R3 International is now offering stem cell therapy for ... cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with ... form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... announced that the launch of a new clinical diagnostics immuno-oncology service, ... tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, ...
(Date:6/28/2020)... ... 26, 2020 , ... The Security Industry Association ... opposition to the recently introduced bicameral Facial Recognition and Biometric Technology Moratorium ... use of nearly all biometric and related image analytics technologies, incorrectly labeling all ...
Breaking Biology Technology:
(Date:7/31/2020)... ... July 30, 2020 , ... ... product portfolio with a near term focus on Type 2 diabetes and associated ... experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... Today CJ ... Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient ... The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):